Post-stroke complications: Epidemiology and prospects for pharmacological intervention during rehabilitation

James F. Meschia, Askiel Bruno

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Stroke can be associated with a number of sequelae which require treatment during rehabilitation of the patient. These include aphasia, depression and emotionalism, central pain, spasticity and urinary incontinence. Patients will also require rehabilitation to optimise motor recovery. At present, no reliable evidence favours any drug for the treatment of aphasia or post-stroke urinary incontinence. On the basis of small, unconfirmed. randomised trials, a tentative recommendation can be made for the use of the antidepressants nortriptyline, citalopram, maprotiline or fluoxetine in post-stroke depression. and nortriptyline or citalopram in post-stroke emotionalism. The tricyclic antidepressant amitriptyline appears to be useful for the control of central post-stroke pain, and botulinum toxin A should be considered for post-stroke spasticity. Although limited data suggest that amphetamine and dexamphetamine can enhance motor recovery, these drugs remain investigational and their use cannot be recommended outside of clinical trials.

Original languageEnglish (US)
Pages (from-to)357-370
Number of pages14
JournalCNS Drugs
Issue number5
StatePublished - 1998

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)


Dive into the research topics of 'Post-stroke complications: Epidemiology and prospects for pharmacological intervention during rehabilitation'. Together they form a unique fingerprint.

Cite this